TFAM and Parkinson disease: The MitoPark mouse is a transgenic model utilized in studying PD and includes the selective removal of the mitochondrial transcription factor, TFAM, from midbrain dopaminergic neurons, resulting in severe mitochondrial respiratory defects and ultimately cell death [230].